Dental Hemostats Market Size, Share, and Industry Analysis, By Product Type (Active Hemostats, Passive Hemostats, and Others), By Form (Surgical Hemostat Sponges, Dental Hemostatic Powder, Dental Hemostatic Gel, and Others), By Application (Endodontics, Oral & Maxillofacial Surgery, Prosthodontics, and Others), By End User (Solo Practices, DSO/Group Practices, and Others), and Regional Forecast 2025-2032

The dental hemostats market is witnessing significant growth due to a surge in the volume of dental surgeries, advancements in the hemostatic agents, and the shift toward minimally invasive dentistry. Together, these factors are expected to boost the utilization of dental hemostats, thereby driving global market growth in the coming years.

• For instance, according to the article published by Healthline Media LLC in July 2020, tooth surgery is the most common oral surgery, accounting for more than 5.0 million individuals undergoing tooth extraction globally.

Dental Hemostats Market Driver

Increasing Number of Dental Procedures Globally Boosts Market Growth

The prevalence of dental diseases worldwide is leading to a rise in the volume of dental procedures, such as tooth extraction, which involves the utilization of hemostats to stop the bleeding. This is driving the demand for dental hemostats in dental care facilities, which is anticipated to propel the global market growth in the forthcoming years.

• For instance, according to the data published by GOV.UK. in February 2024, there was a 17.0% surge in the number of episodes of decay-related tooth extractions in NHS hospitals for 0 to 19-year-olds in the financial year 2022 to 2023 compared to the previous financial year of 2021 to 2022.

Download Free sample to learn more about this report.

Dental Hemostats Market Restraint

Competition from Alternative Products May Hamper Market Growth

Dental hemostats face competition from other bleeding control methods, such as sutures and fibrin sealants. These alternatives may be preferred in certain situations due to their established efficacy and familiarity among dental practitioners, which can limit the market growth for dental hemostats during the forecast period.

• For instance, as per the article published by the National Center for Biotechnology Information (NCBI) in May 2023, resorbable sutures are most often the surgeon's primary choice in modern dental surgeries.

Dental Hemostats Market Opportunity

Technological Advancements for Production of Dental Materials to Offer Several Growth Opportunities

Recent advancements in hemostatic agents, such as collagen-based and platelet-rich fibrin matrices, offer improved wound healing and reduced bleeding during dental procedures. These agents are more effective and easier to use compared to traditional methods, which may lead to their increased adoption by dentists, driving market expansion in the near future.

• For instance, as per the International Journal of Implant Dentistry in December 2021, 66.6% of the studies reported that platelet-rich fibrin PRF significantly reduced postoperative pain, especially in the first 1 to 3 days after tooth extraction procedure.

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence of Key Diseases, By Key Countries/Region, 2023
• Key Industry Developments (Mergers, Acquisitions, Partnerships)
• Estimated Number of Dentists, By Key Countries/Region, 2023
• Overview: Technological Advancements in Dental Hemostats
• Impact of COVID-19 on the Market

Analysis by Product Type

By product type, the market is divided into active hemostats, passive hemostats, and others.

The passive hemostats accounted for a significant market share in 2023. Passive hemostatic agents are favored in dentistry due to their cost-effectiveness, ease of use, and sufficient efficacy in managing bleeding during dental procedures. Such a scenario is expected to boost the segment growth during the forecast period.

• For instance, according to the Galore International Journal of Health Sciences and Research, passive hemostats are generally used as first-line agents due to ease of availability, no special storage requirement, and other benefits.

Analysis by Form

By form, the market is divided into surgical hemostat sponges, dental hemostatic powder, dental hemostatic gel, and others.

The surgical hemostat sponges segment accounted for a prominent share of the global dental hemostats market in 2023. Surgical hemostat sponges tend to be the most preferred choice due to their comprehensive benefits in managing bleeding and facilitating healing. This stimulates the distributor to increase the supply of such products, which is expected to boost the segment's growth.

• For instance, as of September 2024, Dentaltix, a supplies distributor, is distributing Gelatamp hemostatic sponges in France, Italy, Portugal, and Spain.

Analysis by Application

By application, the market is divided into endodontics, oral & maxillofacial surgery, prosthodontics, and others.

The oral and maxillofacial surgery segment accounted for a substantial share of the global dental hemostats market in 2023. The growth of the segment can be attributed to the rising number of oral and maxillofacial surgeries globally, particularly dental extraction, that involves the use of hemostats for bleeding control.

• For instance, as per the article published by the National Center for Biotechnology Information in August 2023, hemostatic agents have been used for a long time to control bleeding in oral surgery, benefiting from their low systemic resorption when applied topically. Moreover, the article also mentioned that dental extraction is a common procedure performed in oral and maxillofacial surgery clinics.

Analysis by End User

By end user, the market is divided into solo practices, DSO/group practices, and others.

The solo practices segment is projected to grow at a substantial rate in the coming years. The segment’s growth is attributable to the increasing number of dentists globally, which is contributing to the large number of dental surgeries performed in solo practices. This is expected to boost the demand for dental hemostats in solo practices.

• For instance, according to the American Dental Association, 202,304 professionally active dentists are currently working in the U.S.

Regional Analysis

To gain extensive insights into the market, Download for Customization

In terms of geography, the global market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for the largest share of the global dental hemostats market in 2023. The region’s growth is attributed to the rising prevalence of dental health issues such as tooth decay, which may further necessitate tooth extraction procedures. This involves the use of dental hemostats to control postoperative bleeding, which is anticipated to boost the regional market growth during the forecast period.

• For instance, in December 2022, Byte published that 1 in 4 U.S. adults have untreated tooth decay. This may further require tooth extraction, which is expected to boost the utilization of dental hemostats.

Europe is the second-largest market based on the demand for dental hemostats. The growth is attributed to the growing number of patient visits to dental clinics, which contributes to the number of dental procedures performed in the region. Such a scenario is expected to boost the demand for dental hemostats in the region.

• For instance, as per the data published by GOV.U.K. in February 2024, London reported around 333 decayed tooth extraction rates per 100,000 population for the financial year 2022 to 2023.

Asia Pacific is expected to grow at the fastest CAGR during the forecast period. The region’s growth can be attributed to emerging destinations for dental procedures, such as India and Japan, which may propel the adoption of dental hemostats in the region.

Key Players Covered

The global dental hemostats market is fragmented, with a large number of companies offering various dental hemostats for dental products.

The report includes the profiles of the following key players:

• Henry Schein Inc. (U.S.)
• DSI LTD (Israel)
• J & J Instruments, Inc. (U.S.)
• Ultradent Products Inc. (U.S.)
• Aegis Lifesciences (India)
• Vista Apex (U.S.)
• Hu-Friedy Mfg. Co., LLC. (U.S.)
• ASA DENTAL (Italy)

Key Industry Developments

• In January 2023, Medcura, Inc. received the U.S. FDA approval for its LifeGel absorbable surgical hemostat, the first and only hemostatic agent seeking a new and highly differentiated indication, excluding ophthalmic and urological indications.
• In September 2024, a new dental services organization (DSO) was launched in Nashville, U.S., which may contribute to the use of dental hemostats to con